{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T14:35:59Z","timestamp":1794666959461,"version":"4.9.1"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100010937","name":"St. John's University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010937","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.ijbiomac.2024.131491","type":"journal-article","created":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T22:18:29Z","timestamp":1712614709000},"page":"131491","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"P2","title":["Mucoadhesive chitosan-poly (lactic-co-glycolic acid) nanoparticles for intranasal delivery of quetiapine \u2013 Development &amp; characterization in physiologically relevant 3D tissue models"],"prefix":"10.1016","volume":"267","author":[{"given":"Dnyandev G.","family":"Gadhave","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mural","family":"Quadros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akanksha R.","family":"Ugale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mimansa","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyoum","family":"Ayehunie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2024.131491_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121050","article-title":"Nose-to-brain delivery of amisulpride-loaded lipid-based poloxamer-gellan gum nanoemulgel: in vitro and in vivo pharmacological studies","volume":"607","author":"Gadhave","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2024.131491_bb0010","doi-asserted-by":"crossref","first-page":"4169","DOI":"10.1016\/j.actbio.2011.07.025","article-title":"Development and evaluation of olanzapine-loaded PLGA nanoparticles for nose-to-brain delivery: in vitro and in vivo studies","volume":"7","author":"Seju","year":"2011","journal-title":"Acta Biomater."},{"key":"10.1016\/j.ijbiomac.2024.131491_bb0015","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.pharma.2022.08.010","article-title":"Nose-to-brain delivery of paliperidone palmitate poloxamer-guar gum nanogel: formulation, optimization and pharmacological studies in rats","volume":"81","author":"Gadhave","year":"2023","journal-title":"Ann. Pharm. Fr."},{"key":"10.1016\/j.ijbiomac.2024.131491_bb0020","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1208\/s12249-018-1213-y","article-title":"Agranulocytosis-protective olanzapine-loaded nanostructured lipid carriers engineered for CNS delivery: optimization and hematological toxicity studies","volume":"20","author":"Gadhave","year":"2019","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijbiomac.2024.131491_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120250","article-title":"Nose-to-brain delivery of disulfiram nanoemulsion in situ gel formulation for glioblastoma targeting therapy","volume":"597","author":"Qu","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2024.131491_bb0030","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jconrel.2015.06.002","article-title":"PLGA nanoparticles prepared by nano-emulsion templating using low-energy methods as efficient nanocarriers for drug delivery across the blood\u2013brain barrier","volume":"211","author":"Fornaguera","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2024.131491_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2023.148674","article-title":"Potential biomaterials and experimental animal models for inventing new drug delivery approaches in the neurodegenerative disorder: multiple sclerosis","volume":"1822","author":"Gadhave","year":"2024","journal-title":"Brain Res."},{"key":"10.1016\/j.ijbiomac.2024.131491_bb0040","series-title":"Quetiapine, in: StatPearls","author":"Maan","year":"2024"},{"key":"10.1016\/j.ijbiomac.2024.131491_bb0045","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ejps.2016.05.008","article-title":"Non-invasive intranasal delivery of quetiapine fumarate loaded microemulsion for brain targeting: formulation, physicochemical and pharmacokinetic consideration","volume":"91","author":"Shah","year":"2016","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijbiomac.2024.131491_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110707","article-title":"The impact of quetiapine on the brain lipidome in a cuprizone-induced mouse model of schizophrenia","volume":"131","author":"Zhou","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ijbiomac.2024.131491_bb0055","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s12888-015-0495-9","article-title":"Quetiapine-associated leucopenia and thrombocytopenia: a case report","volume":"15","author":"Fan","year":"2015","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.ijbiomac.2024.131491_bb0060","first-page":"319","article-title":"Neutropenia and thrombocytopenia induced by quetiapine monotherapy: a case report and review of literature, Klinik Psikofarmakoloji B\u00fclteni-bulletin of clinical","volume":"26","author":"Arslan","year":"2016","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ijbiomac.2024.131491_bb0065","first-page":"151","article-title":"Quetiapine XR-induced neutropenia: is a clozapine trial still possible for treatment-resistant schizophrenia?","volume":"9","author":"Cr\u00e9peau-Gendron","year":"2015","journal-title":"A case report: Clozapine after quetiapine XR-induced neutropenia, Early Intervention in Psychiatry"},{"key":"10.1016\/j.ijbiomac.2024.131491_bb0070","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1176\/appi.psy.48.6.530","article-title":"Quetiapine-induced leucopenia and thrombocytopenia","volume":"48","author":"Ravi Shankar","year":"2007","journal-title":"Psychosomatics"},{"key":"10.1016\/j.ijbiomac.2024.131491_bb0075","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1021\/tx2005635","article-title":"Potential role of a quetiapine metabolite in quetiapine-induced neutropenia and agranulocytosis","volume":"25","author":"Li","year":"2012","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.ijbiomac.2024.131491_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.122372","article-title":"Nose-to-brain delivery of octreotide acetate in situ gel for pituitary adenoma: pharmacological and in vitro cytotoxicity studies","volume":"629","author":"Gadhave","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2024.131491_bb0085","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/j.xphs.2021.01.021","article-title":"Antipsychotic potential and safety profile of TPGS-based Mucoadhesive aripiprazole Nanoemulsion: development and optimization for nose-to-brain delivery","volume":"110","author":"Kumbhar","year":"2021","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijbiomac.2024.131491_bb0090","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s43094-020-00156-5","article-title":"Comparative evaluation of intranasally delivered quetiapine loaded mucoadhesive microemulsion and polymeric nanoparticles for brain targeting: pharmacokinetic and gamma scintigraphy studies","volume":"7","author":"Shah","year":"2021","journal-title":"Futur J Pharm Sci"},{"key":"10.1016\/j.ijbiomac.2024.131491_bb0095","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.apsb.2014.02.002","article-title":"Role of mucoadhesive polymers in enhancing delivery of nimodipine microemulsion to brain via intranasal route","volume":"4","author":"Pathak","year":"2014","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ijbiomac.2024.131491_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121563","article-title":"Nose-to-brain delivery of simvastatin mediated by chitosan-coated lipid-core nanocapsules allows for the treatment of glioblastoma in vivo","volume":"616","author":"Bruinsmann","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2024.131491_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121720","article-title":"Thermosensitive in situ hydrogels of rivastigmine-loaded lipid-based nanosystems for nose-to-brain delivery: characterisation, biocompatibility, and drug deposition studies","volume":"620","author":"Cunha","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2024.131491_bb0110","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jddst.2019.02.013","article-title":"Intranasal teriflunomide microemulsion: an improved chemotherapeutic approach in glioblastoma","volume":"51","author":"Gadhave","year":"2019","journal-title":"Journal of Drug Delivery Science and Technology"},{"key":"10.1016\/j.ijbiomac.2024.131491_bb0115","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.addr.2011.12.005","article-title":"Drug delivery to the brain in Alzheimer\u2019s disease: consideration of the blood\u2013brain barrier","volume":"64","author":"Banks","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijbiomac.2024.131491_bb0120","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.ijbiomac.2014.03.022","article-title":"Ali, donepezil nanosuspension intended for nose to brain targeting: in vitro and in vivo safety evaluation","volume":"67","author":"Bhavna","year":"2014","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2024.131491_bb0125","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.ijbiomac.2018.03.117","article-title":"Nanostructured lipid carrier-based pH and temperature dual-responsive hydrogel composed of carboxymethyl chitosan and poloxamer for drug delivery","volume":"114","author":"Yu","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2024.131491_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2022.103923","article-title":"Nose to brain delivery of selegiline loaded PLGA\/lipid nanoparticles: synthesis, characterisation and brain pharmacokinetics evaluation","volume":"77","author":"Raman","year":"2022","journal-title":"Journal of Drug Delivery Science and Technology"},{"key":"10.1016\/j.ijbiomac.2024.131491_bb0135","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1080\/10826076.2017.1343735","article-title":"Rasagiline-encapsulated chitosan-coated PLGA nanoparticles targeted to the brain in the treatment of parkinson\u2019s disease","volume":"40","author":"Ahmad","year":"2017","journal-title":"J. Liq. Chromatogr. Relat. Technol."},{"key":"10.1016\/j.ijbiomac.2024.131491_bb0140","article-title":"Development and characterization of inhaled nintedanib-loaded PLGA nanoparticles using scalable high-pressure homogenization technique","author":"Wang","year":"2023","journal-title":"Journal of Drug Delivery Science and Technology"},{"key":"10.1016\/j.ijbiomac.2024.131491_bb0145","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.jsps.2016.12.003","article-title":"Development and evaluation of Desvenlafaxine loaded PLGA-chitosan nanoparticles for brain delivery","volume":"25","author":"Tong","year":"2017","journal-title":"Saudi Pharmaceutical Journal"},{"key":"10.1016\/j.ijbiomac.2024.131491_bb0150","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.ijbiomac.2022.08.210","article-title":"Brain targeted delivery of carmustine using chitosan coated nanoparticles via nasal route for glioblastoma treatment","volume":"221","author":"Ahmad","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2024.131491_bb0155","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ijbiomac.2018.10.181","article-title":"Cyclodextrin modified erlotinib loaded PLGA nanoparticles for improved therapeutic efficacy against non-small cell lung cancer","volume":"122","author":"Vaidya","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2024.131491_bb0160","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s13346-020-00802-8","article-title":"Afatinib-loaded inhalable PLGA nanoparticles for localized therapy of non-small cell lung cancer (NSCLC)\u2014development and in-vitro efficacy","volume":"11","author":"Elbatanony","year":"2021","journal-title":"Drug Deliv. and Transl. Res."},{"key":"10.1016\/j.ijbiomac.2024.131491_bb0165","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.sjbs.2019.11.008","article-title":"Poloxamer-chitosan-based Naringenin nanoformulation used in brain targeting for the treatment of cerebral ischemia","volume":"27","author":"Ahmad","year":"2020","journal-title":"Saudi Journal of Biological Sciences"},{"key":"10.1016\/j.ijbiomac.2024.131491_bb0170","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1080\/02713683.2021.1916037","article-title":"Optimization and characterization of Brimonidine tartrate nanoparticles-loaded in situ gel for the treatment of Glaucoma","volume":"46","author":"Sharma","year":"2021","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.ijbiomac.2024.131491_bb0175","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.ijbiomac.2020.11.047","article-title":"Nose-to-brain delivery of teriflunomide-loaded lipid-based carbopol-gellan gum nanogel for glioma: pharmacological and in vitro cytotoxicity studies","volume":"167","author":"Gadhave","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2024.131491_bb0180","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s11095-020-02848-2","article-title":"Nanotechnology based repositioning of an anti-viral drug for non-small cell lung Cancer (NSCLC)","volume":"37","author":"Parvathaneni","year":"2020","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijbiomac.2024.131491_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2020.111139","article-title":"Development of pharmaceutically scalable inhaled anti-cancer nanotherapy \u2013 repurposing amodiaquine for non-small cell lung cancer (NSCLC)","volume":"115","author":"Parvathaneni","year":"2020","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.ijbiomac.2024.131491_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121038","article-title":"Development and characterization of inhalable transferrin functionalized amodiaquine nanoparticles \u2013 efficacy in non-small cell lung Cancer (NSCLC) treatment","volume":"608","author":"Parvathaneni","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2024.131491_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119499","article-title":"Preparation, characterization, and optimization of asenapine maleate mucoadhesive nanoemulsion using box-Behnken design: in vitro and in vivo studies for brain targeting","volume":"586","author":"Kumbhar","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2024.131491_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119776","article-title":"Chitosan-coated PLGA nanoparticles for the nasal delivery of ropinirole hydrochloride: in vitro and ex vivo evaluation of efficacy and safety","volume":"589","author":"Chatzitaki","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2024.131491_bb0205","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s13204-018-0909-3","article-title":"Neutropenia and leukopenia protective intranasal olanzapine-loaded lipid-based nanocarriers engineered for brain delivery","volume":"9","author":"Gadhave","year":"2019","journal-title":"Appl. Nanosci."},{"key":"10.1016\/j.ijbiomac.2024.131491_bb0210","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1080\/03639045.2019.1576724","article-title":"Nanostructured lipid carriers engineered for intranasal delivery of teriflunomide in multiple sclerosis: optimization and in vivo studies","volume":"45","author":"Gadhave","year":"2019","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ijbiomac.2024.131491_bb0215","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ijbiomac.2020.05.146","article-title":"Metformin-loaded chitosomes for treatment of malignant pleural mesothelioma \u2013 a rare thoracic cancer","volume":"160","author":"Shukla","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2024.131491_bb0220","doi-asserted-by":"crossref","unstructured":"H. Van De Ven, C. Paulussen, P.B. Feijens, A. Matheeussen, P. Rombaut, P. Kayaert, G. Van Den Mooter, W. Weyenberg, P. Cos, L. Maes, A. Ludwig, PLGA nanoparticles and nanosuspensions with amphotericin B: Potent in vitro and in vivo alternatives to Fungizone and AmBisome, J. Control. Release 161 (2012) 795\u2013803. doi:https:\/\/doi.org\/10.1016\/j.jconrel.2012.05.037.","DOI":"10.1016\/j.jconrel.2012.05.037"},{"key":"10.1016\/j.ijbiomac.2024.131491_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112286","article-title":"Ajazuddin, development and optimization of paclitaxel loaded Eudragit\/PLGA nanoparticles by simplex lattice mixture design: exploration of improved hemocompatibility and in vivo kinetics","volume":"144","author":"Jeswani","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ijbiomac.2024.131491_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2019.110576","article-title":"Lipid-PLGA hybrid nanoparticles of paclitaxel: preparation, characterization, in vitro and in vivo evaluation","volume":"109","author":"Godara","year":"2020","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.ijbiomac.2024.131491_bb0235","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.ijbiomac.2020.07.124","article-title":"Inhalable resveratrol-cyclodextrin complex loaded biodegradable nanoparticles for enhanced efficacy against non-small cell lung cancer","volume":"164","author":"Wang","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2024.131491_bb0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2016.09.086","article-title":"Application of RPMI 2650 as a cell model to evaluate solid formulations for intranasal delivery of drugs","volume":"515","author":"Gon\u00e7alves","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2024.131491_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2023.104767","article-title":"Poly vinyl pyrrolidone (PVP) based inhaled delivery carriers for olaparib for non-small cell lung cancer (NSCLC) treatment","volume":"87","author":"Goyal","year":"2023","journal-title":"Journal of Drug Delivery Science and Technology"},{"key":"10.1016\/j.ijbiomac.2024.131491_bb0250","doi-asserted-by":"crossref","unstructured":"IJMS | Free Full-Text | Repurposing Bedaquiline for Effective Non-Small Cell Lung Cancer (NSCLC) Therapy as Inhalable Cyclodextrin-Based Molecular Inclusion Complexes, (n.d.). https: \/\/www.mdpi.com\/1422-0067\/22\/9\/4783 (accessed October 17, 2023).","DOI":"10.3390\/ijms22094783"},{"key":"10.1016\/j.ijbiomac.2024.131491_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118995","article-title":"Development of inhalable quinacrine loaded bovine serum albumin modified cationic nanoparticles: repurposing quinacrine for lung cancer therapeutics","volume":"577","author":"Vaidya","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2024.131491_bb0260","doi-asserted-by":"crossref","first-page":"935","DOI":"10.2217\/nnm-2022-0045","article-title":"Cationically modified inhalable nintedanib niosomes: enhancing therapeutic activity against non-small-cell lung cancer","volume":"17","author":"Shukla","year":"2022","journal-title":"Nanomedicine"},{"key":"10.1016\/j.ijbiomac.2024.131491_bb0265","doi-asserted-by":"crossref","first-page":"194","DOI":"10.3390\/pharmaceutics14010194","article-title":"In vitro evaluation of curcumin- and quercetin-loaded Nanoemulsions for intranasal administration: effect of surface charge and viscosity","volume":"14","author":"Vaz","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijbiomac.2024.131491_bb0270","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3390\/pharmaceutics11080367","article-title":"Improved in vitro model for intranasal mucosal drug delivery: primary olfactory and respiratory epithelial cells compared with the permanent nasal cell line RPMI 2650","volume":"11","author":"Ladel","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijbiomac.2024.131491_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2019.101301","article-title":"Formulation development and evaluation of rotigotine mucoadhesive nanoemulsion for intranasal delivery","volume":"54","author":"Choudhury","year":"2019","journal-title":"Journal of Drug Delivery Science and Technology"},{"key":"10.1016\/j.ijbiomac.2024.131491_bb0280","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1080\/03639045.2019.1619759","article-title":"Formulation and biopharmaceutical evaluation of risperidone-loaded chitosan nanoparticles for intranasal delivery","volume":"45","author":"Rukmangathen","year":"2019","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ijbiomac.2024.131491_bb0285","doi-asserted-by":"crossref","unstructured":"V. Fryer, J. Billings, Low-dose quetiapine causing agranulocytosis and leucopenia in a patient with benign neutropenia: a case report, Cureus 12 (n.d.) e8505. doi:https:\/\/doi.org\/10.7759\/cureus.8505.","DOI":"10.7759\/cureus.8505"},{"key":"10.1016\/j.ijbiomac.2024.131491_bb0290","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222413258","article-title":"In vitro comparative study of solid lipid and PLGA nanoparticles designed to facilitate nose-to-brain delivery of insulin","volume":"22","author":"Akel","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2024.131491_bb0295","article-title":"Formulation and optimization of polymeric nanoparticles for intranasal delivery of lorazepam using box-Behnken design","volume":"2014","author":"Sharma","year":"2014","journal-title":"In Vitro and In Vivo Evaluation, Biomed Res Int"},{"key":"10.1016\/j.ijbiomac.2024.131491_bb0300","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1080\/10837450.2019.1659818","article-title":"Efavirenz-loaded intranasal microemulsion for crossing blood-CNS interfaces in neuronal-AIDS: pharmacokinetic and in vivo safety evaluation","volume":"25","author":"Kokare","year":"2020","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.ijbiomac.2024.131491_bb0305","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1080\/21691401.2021.1939709","article-title":"Lamotrigine loaded PLGA nanoparticles intended for direct nose to brain delivery in epilepsy: pharmacokinetic, pharmacodynamic and scintigraphy study","volume":"49","author":"Shah","year":"2021","journal-title":"Artificial Cells, Nanomedicine, and Biotechnology"},{"key":"10.1016\/j.ijbiomac.2024.131491_bb0310","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.2147\/IJN.S236922","article-title":"Rhynchophylline loaded-mPEG-PLGA nanoparticles coated with Tween-80 for preliminary study in Alzheimer\u2019s disease","volume":"15","author":"Xu","year":"2020","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ijbiomac.2024.131491_bb0315","doi-asserted-by":"crossref","first-page":"501","DOI":"10.9758\/cpn.2018.16.4.501","article-title":"Quetiapine induced autoimmune hemolytic Anemia in a child patient: a case report","volume":"16","author":"Arici","year":"2018","journal-title":"Clin Psychopharmacol Neurosci"},{"key":"10.1016\/j.ijbiomac.2024.131491_bb0320","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.msec.2016.03.015","article-title":"Thermosensitive PLA based nanodispersion for targeting brain tumor via intranasal route","volume":"63","author":"Jain","year":"2016","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.ijbiomac.2024.131491_bb0325","doi-asserted-by":"crossref","unstructured":"Q. Liang, H. Xiang, X. Li, C. Luo, X. Ma, W. Zhao, J. Chen, Z. Tian, X. Li, X. Song, <p>development of Rifapentine-loaded PLGA-based nanoparticles: in vitro characterisation and in vivo study in mice<\/p>, IJN 15 (2020) 7491\u20137507. doi:https:\/\/doi.org\/10.2147\/IJN.S257758.","DOI":"10.2147\/IJN.S257758"},{"key":"10.1016\/j.ijbiomac.2024.131491_bb0330","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ejpb.2020.02.004","article-title":"Quantitative estimation of drug permeation through nasal mucosa using in vitro membrane permeability across Calu-3 cell layers for predicting in vivo bioavailability after intranasal administration to rats","volume":"149","author":"Inoue","year":"2020","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijbiomac.2024.131491_bb0335","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ijpharm.2006.11.013","article-title":"In vitro formulation optimization of intranasal galantamine leading to enhanced bioavailability and reduced emetic response in vivo","volume":"335","author":"Leonard","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2024.131491_bb0340","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1007\/s11095-022-03218-w","article-title":"In-vivo and ex-vivo brain uptake studies of Peptidomimetic Neurolysin activators in healthy and stroke animals","volume":"39","author":"Nozohouri","year":"2022","journal-title":"Pharm. Res."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813024022967?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813024022967?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T09:04:07Z","timestamp":1715159047000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813024022967"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":68,"alternative-id":["S0141813024022967"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.131491","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mucoadhesive chitosan-poly (lactic-co-glycolic acid) nanoparticles for intranasal delivery of quetiapine \u2013 Development & characterization in physiologically relevant 3D tissue models","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.131491","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"131491"}}